GlassScriptPhysician profile
Katie Baker
NPI 1346691862
$3,536.96
in general payments reported to CMS, 2019-2025
34 companies · $951 in 2025
The $951 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $657 · 2023: $888 · 2024: $678 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,516.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $386.58 | 2022-2025 | |
| Boston Scientific Corporation | $323.25 | 2021-2025 | Watchman Flx, Watchman Access System, Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $259.73 | 2021-2024 | Jardiance |
| Amgen INC. | $248.42 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $244.72 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.45 | 2021-2025 | Lifevest |
| Abbott Laboratories | $179.76 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| E.R. Squibb & Sons, L.L.C. | $171.20 | 2021-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $132.12 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $128.53 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Novo Nordisk INC | $127.14 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $121.56 | 2021-2025 | Verquvo, Capvaxive |
| Baxter Healthcare | $107.10 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $97.99 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $97.92 | 2022-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $86.87 | 2023-2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $66.13 | 2023-2024 | Onpattro |
| Bridgebio Pharma, INC. | $60.10 | 2025 | Attruby |
| Abiomed | $57.03 | 2025 | |
| Atricure, INC. | $44.89 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Lexicon Pharmaceuticals, INC. | $42.50 | 2023-2024 | Inpefa |
| Lilly USA, LLC | $42.09 | 2025 | Zepbound |
| Medtronic, INC. | $33.43 | 2022-2024 | Ffrangio |
| Edwards Lifesciences Corporation | $32.22 | 2022-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medicomp INC | $29.30 | 2022 | |
| Philips North America LLC | $27.86 | 2022 | |
| Kestra Medical Technology Services, INC. | $24.88 | 2025 | Assure Wcd |
| Collegium Pharmaceutical, INC. | $22.00 | 2025 | Xtampza |
| Kiniksa Pharmaceuticals International, Plc | $20.88 | 2024 | Arcalyst |
| Biosense Webster, INC. | $18.90 | 2023 | Octaray Mapping Catheter |
| Heartflow, INC. | $18.17 | 2024 | |
| Esperion Therapeutics, INC. | $17.89 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.97 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $8.38 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.